查找临床试验
已按「淋巴瘤」检索，对应国际通用词 lymphoma
共找到 12 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 09:59，每 5 分钟自动同步正在招募III 期中国有中心NCT06496308
Bendamustine and Rituximab With or Without Orelabrutinib in MCL Treatment
China
年龄 18 Years – 80 Years
Ruijin Hospital
正在招募不适用中国有中心NCT06795113
Optimization of 18F-FDG PET/CT Response Assessment and Prognostic Evaluation Strategies for High-Metabolism Lymphoma
China
年龄 18 Years – 100 Years
Ruijin Hospital
正在招募I 期中国有中心NCT06690827
Clinical Trial of CD123-targeted CAR-NK Therapy for Relapse/Refractory AML or BPDCN
China
年龄 18 Years – 75 Years
Chongqing Precision Biotech Co., Ltd
正在招募早期 I 期中国有中心NCT06633341
Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-lymphoma
China
年龄 不限 – 不限
Zhejiang University
正在招募II 期中国有中心NCT05933967
A Study of Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With Double Expression Diffuse Large B-cell Lymphoma
China
年龄 18 Years – 70 Years
Shandong Cancer Hospital and Institute
正在招募I 期中国有中心NCT07260812
KSV01 Injection for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
China
年龄 18 Years – 65 Years
TCRx Therapeutics Co.Ltd
正在招募III 期中国有中心NCT07409428
A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL
China
年龄 18 Years – 不限
Hutchmed
正在招募II 期中国有中心NCT06701357
CR-CHOP+X in Previously Untreated DEL
China
年龄 18 Years – 75 Years
Ruijin Hospital
正在招募I 期中国有中心NCT06703892
A Study to Evaluate the Safety and Clinical Activity of GF- CART01 (CD20/19 CAR T Cell) in Subjects With Relapsed or Refractory B-Cell Hematological Malignancies
Taiwan
年龄 18 Years – 70 Years
GenomeFrontier Therapeutics TW Co., Ltd.
正在招募I 期 / II 期中国有中心NCT06948981
GT719 Injection for the Treatment of Recurrent/Refractory CD19 Positive Adult B-cell Malignancies
China
年龄 18 Years – 75 Years
Grit Biotechnology
正在招募早期 I 期中国有中心NCT06346912
CD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHL
China
年龄 18 Years – 不限
Zhejiang University
正在招募不适用中国有中心NCT07188077
Metabolic and Immunomic Differential Analysis of Primary Central Nervous System Diffuse Large B-Cell Lymphoma
China
年龄 18 Years – 75 Years
Ting YANG